Allergy Therapeutics (AGY.LSE) Q3 2025 Earnings

30SepConfirmed
Q1 2024
Q4 2024
Q1 2025
Q3 2025
-0.51
-0.41
-0.32
-0.22

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Allergy Therapeutics (AGY.LSE) will report earnings of for Q3 2025 on September 30, 2025.

0 Comments

Share your thoughts